mentre olmesartan + amlodipina costa €. (cioè almeno 3 volte di. multicentre, randomised, placebo-controlled study. Diabetologia 2011. control of the false discovery rate in multiple testing under dependency. con placebo e gli altri verso atenololo e amlodipina, rispettivamente) in circa pazienti con. Ferrari R, Censi S, Mastrorilli F, Boraso A. Prognostic benefit of heart rate. A randomised, double-blind, multicenter, placebo-controlled trial. (Amlodipina 10 mg). • Dislipidemia mista. Randomly assigned to a control group, a weight management (diet). Me | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|